ORIGINAL RESEARCH article

Front. Pediatr.

Sec. Pediatric Infectious Diseases

Volume 13 - 2025 | doi: 10.3389/fped.2025.1593190

The clinical manifestation and diagnostic features of Kawasaki-like phenotypes in pediatric multisystem inflammatory syndrome: a comparative retrospective study in Ukraine

Provisionally accepted
Nataliia  Yaroslavivna Bodnarchuk-SokhatskaNataliia Yaroslavivna Bodnarchuk-Sokhatska1*Halyna  Andriivna PavlyshynHalyna Andriivna Pavlyshyn1Kateryna  KozakKateryna Kozak1Iryna  AvramenkoIryna Avramenko2
  • 1Ternopil State Medical University, Ternopil, Ukraine
  • 2Danylo Halytsky Lviv National Medical University, Lviv, Ukraine

The final, formatted version of the article will be published soon.

Background: The clinical overlap syndrome between multisystem inflammatory syndrome in children (MIS-C) and Kawasaki disease (KD), particularly in the context of SARS-CoV-2 infection, presents diagnostic challenges. The presence of both complete and incomplete Kawasaki-like phenotypes (KLP) further complicates differentiation. This study aimed to analyze Kawasaki-like phenotype of MIS-C, its clinical features, and improve diagnostic accuracy, patient outcomes.Methods: A retrospective cohort study was conducted on 48 pediatric patients diagnosed with MIS-С between 2020 and 2022. All cases met the MIS-C diagnostic criteria established by the Council of State and Territorial Epidemiologists (2022) and were classified according to the American Heart Association Kawasaki disease criteria (2017). Patients were grouped as non–Kawasaki-like or Kawasaki-like MIS-C phenotypes, with the latter subdivided into complete and incomplete subtypes. Clinical and echocardiographic features were compared using appropriate statistical methods.Results: Among the 48 MIS-C cases analyzed, 22 patients (46%) met the Kawasaki disease criteria, equally divided between complete and incomplete Kawasaki-like phenotypes. btion was longest in the complete phenotype (9.7 days) and shortest in the incomplete phenotype (5.5 days). Patients with neurological involvement experienced longer febrile periods (8.3 vs. 5.4 days). All 100 % patients with the complete phenotype exhibited neurological symptoms versus 46% of incomplete cases. Half of the Kawasaki-like phenotype patients demonstrated echocardiographic abnormalities versus 15% of non–Kawasaki-like (NKL); highest in the incomplete phenotype (91%) compared to 15% in non–Kawasaki-like and 9% in complete KLP. The highest incidence of coronary dilatation was recorded in the incomplete phenotype (73%) versus 9% in the complete and 15% in the non–Kawasaki-like MIS-C.Discussion: Kawasaki-like MIS-C phenotypes display distinct clinical and cardiovascular profiles. Accurate phenotypic identification is crucial for risk stratification and optimizing patient management. Further research is necessary to refine classification criteria and establish effective long-term monitoring strategies for affected children.

Keywords: Multisystem inflammatory syndrome in children, kawasaki disease, SARS-CoV-2, phenotypes, Clinical Characteristics

Received: 13 Mar 2025; Accepted: 18 Jun 2025.

Copyright: © 2025 Bodnarchuk-Sokhatska, Pavlyshyn, Kozak and Avramenko. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Nataliia Yaroslavivna Bodnarchuk-Sokhatska, Ternopil State Medical University, Ternopil, Ukraine

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.